The Research and Development Team at ExeVir is responsible for pioneering the discovery and optimization of single-domain antibody therapies aimed at combating viral infections. They conduct cutting-edge research, oversee preclinical development, and collaborate closely to advance the company's lead drug candidate in the fight against COVID-19, ensuring that innovative solutions are effectively transitioned from the lab to clinical application.
View all